Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arduan
2. Bromide, Pipecurium
3. Bromide, Pipecuronium
4. Dibromide Pipecuronium
5. Dibromide, Dihydrate Pipecuronium
6. Dihydrate Pipecuronium Dibromide
7. Pipecurium
8. Pipecurium Bromide
9. Pipecuronium
10. Pipecuronium Dibromide, (16 Alpha)-isomer
11. Pipecuronium Dibromide, (17 Alpha)-isomer
12. Pipecuronium Dibromide, (3 Beta)-isomer
13. Pipecuronium Dibromide, Dihydrate
14. Pipecuronium, Dibromide
15. Rgh 1106
16. Rgh-1106
17. Rgh1106
1. 52212-02-9
2. Pipecurium Bromide
3. Arduan
4. Rgh-1106
5. Rgh 1106
6. R6zty81re1
7. Pipecuronium Bromide Anhydrous
8. Pipecuronium (bromide)
9. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate;dibromide
10. Pipecuronium Bromide Hydrate
11. Pipecuronio Bromuro [spanish]
12. Einecs 257-740-4
13. Unii-r6zty81re1
14. Pipecuronium Bromide [usan:inn:ban]
15. Ncgc00182708-01
16. Dsstox_cid_3478
17. Dsstox_rid_77044
18. Dsstox_gsid_23478
19. Schembl42154
20. 4,4'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1,1-dimethylpiperazinium)dibromide, Diacetate (ester)
21. Chebi:8231
22. Pipecurium Bromide [mi]
23. Chembl1200722
24. Dtxsid8023478
25. Hy-b0743a
26. Tqp0582
27. Pipecuronium Bromide [inn]
28. Pipecuronium Bromide [jan]
29. Pipecuronium Bromide [usan]
30. Pipecuronium Bromide [vandf]
31. Tox21_113014
32. Pipecuronium Bromide [mart.]
33. Akos037653998
34. Pipecuronium Bromide (jan/usan/inn)
35. Ks-1465
36. 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetoxy)androstane-2,16-diyl)bis(1,1-dimethylpiperazinium) Dibromide
37. Pipecuronium Bromide [orange Book]
38. Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-, Dibromide
39. Piperazinium, 4,4'-(3,17-dihydroxyandrostan-2,16-diyl)bis(1,1-dimethyl-, Dibromide, Diacetate
40. Cas-52212-02-9
41. Cs-0009634
42. D00764
43. A828983
44. Q-101016
45. Q4363210
46. (2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)androstane Dibromide
47. 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) Dibromide
48. 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium)dibromide
49. 4,4'-(3.alpha.,17.beta.-dihydroxy-5.alpha.-androstan-2.beta.,16.beta.-ylene)bis(1,1-dimethylpiperazinium)dibromide, Diacetate (ester)
50. 4,4\'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) Dibromide
51. Piperazinium, 4,4'-((2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-, Dibromide
52. Piperazinium, 4,4'-[(2
53. A,3
54. A,5
55. A,16
56. A,17
57. A)-3,17-bis(acetyloxy)androstane-2,16-diyl]bis[1,1-dimethyl-, Dibromide (9ci)
Molecular Weight | 762.7 g/mol |
---|---|
Molecular Formula | C35H62Br2N4O4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 762.31173 g/mol |
Monoisotopic Mass | 760.31378 g/mol |
Topological Polar Surface Area | 59.1 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 1060 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Neuromuscular Nondepolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)
Nicotinic Antagonists
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)
M - Musculo-skeletal system
M03 - Muscle relaxants
M03A - Muscle relaxants, peripherally acting agents
M03AC - Other quaternary ammonium compounds
M03AC06 - Pipecuronium bromide
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?